A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Clinical trial NCT04830137 · RECRUITING

Trial details

NCT number: NCT04830137
Sponsor: Nurix Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)Waldenstrom Macroglobulinemia (WM)Mantle Cell Lymphoma (MCL)Marginal Zone Lymphoma (MZL)Follicular Lymphoma (FL)Diffuse Large B-cell Lymphoma (DLBCL)Primary Central Nervous System Lymphoma (PCNSL)

Start date: 2021-05-05
Primary completion: 2026-05-01
Enrollment: 248

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.